Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — hormone delivery systems

An FDA-approved testosterone gel was shown to significantly increase cardiovascular risk in older men — but does this mean testosterone therapy is dangerous? ZRT Laboratory’s research suggests the real problem lies in how testosterone is measured. Venous serum testing dramatically underestimates tissue exposure to topical testosterone, leading to pharmacological overdosing that goes undetected. This article explains why the testing method matters as much as the dose.

Over 25 million women enter menopause each year and face decisions about hormone replacement therapy. But HRT dosing is far from standardised — and the testing method used makes all the difference. This article explores why doses vary so widely and how saliva, blood spot and urine testing can help optimise outcomes.

Explore why many men on topical testosterone replacement therapy may be unintentionally over-dosed due to outdated serum testing methods and misunderstood dosing principles. Learn how saliva and dried blood spot testing better reflect bioavailable testosterone delivered to tissues, why physiological dosing matters, and how excessive testosterone may suppress natural hormone production, reduce receptor sensitivity, and negatively affect long-term symptom management and hormonal balance.

Discover why topical testosterone replacement therapy is frequently over-prescribed and how outdated serum testing methods may fail to reflect true hormone bioavailability. Learn how saliva and dried blood spot testing provide a more accurate picture of tissue hormone delivery, why physiological testosterone dosing matters, and how excessive testosterone may suppress natural production, reduce receptor sensitivity, and impact long-term hormonal balance, energy, mood, libido, and overall men’s health.